This is not the most recent version of the article. View current version (20 JAN 2017)

Intervention Review

Beta-blockers for hypertension

  1. Charles Shey Wiysonge1,*,
  2. Hazel A Bradley2,
  3. Jimmy Volmink3,4,
  4. Bongani M Mayosi5,
  5. Anthony Mbewu6,
  6. Lionel H Opie7

Editorial Group: Cochrane Hypertension Group

Published Online: 14 NOV 2012

Assessed as up-to-date: 27 FEB 2012

DOI: 10.1002/14651858.CD002003.pub4


How to Cite

Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Mbewu A, Opie LH. Beta-blockers for hypertension. Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD002003. DOI: 10.1002/14651858.CD002003.pub4.

Author Information

  1. 1

    University of Cape Town, Division of Medical Microbiology & Institute of Infectious Disease and Molecular Medicine, Observatory, South Africa

  2. 2

    University of the Western Cape, School of Public Health, Cape Town, South Africa

  3. 3

    Stellenbosch University, Faculty of Medicine and Health Sciences, Tygerberg, South Africa

  4. 4

    South African Medical Research Council, South African Cochrane Centre, Tygerberg, Western Cape, South Africa

  5. 5

    J Floor, Old Groote Schuur Hospital, Department of Medicine, Cape Town, South Africa

  6. 6

    University of Cape Town, Department of Medicine, Faculty of Health Sciences, Cape Town, South Africa

  7. 7

    Medical School, Hatter Cardiovascular Research Institute, Cape Town, South Africa

*Charles Shey Wiysonge, Division of Medical Microbiology & Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Anzio Road, Observatory, 7925, South Africa. charles.wiysonge@uct.ac.za. wiysonge@yahoo.com.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 14 NOV 2012

SEARCH

This is not the most recent version of the article. View current version (20 JAN 2017)

  1. You have full text access to this OnlineOpen article

    Current Version

    Beta-blockers for hypertension

    Charles S Wiysonge, Hazel A Bradley, Jimmy Volmink, Bongani M Mayosi and Lionel H Opie

    Version of Record online: 20 JAN 2017 | DOI: 10.1002/14651858.CD002003.pub5

Previous versions of this article and their online publication dates

  1. Version 4

    Beta-blockers for hypertension

    Charles Shey Wiysonge, Hazel A Bradley, Jimmy Volmink, Bongani M Mayosi, Anthony Mbewu and Lionel H Opie

    Version of Record online: 14 NOV 2012 | DOI: 10.1002/14651858.CD002003.pub4

  2. Version 3

    Beta-blockers for hypertension

    Charles Shey Wiysonge, Hazel A Bradley, Jimmy Volmink, Bongani M Mayosi, Anthony Mbewu and Lionel H Opie

    Version of Record online: 15 AUG 2012 | DOI: 10.1002/14651858.CD002003.pub3

  3. Version 2

    Beta-blockers for hypertension

    Charles Shey U. Wiysonge, Hazel A Bradley, Bongani M Mayosi, Roy T Maroney, Anthony Mbewu, Lionel Opie and Jimmy Volmink

    Version of Record online: 24 JAN 2007 | DOI: 10.1002/14651858.CD002003.pub2

  4. Version 1

    Betablockers for hypertension

    J Volmink, H Bradley, R Maroney, A Mbewu and L Opie

    Version of Record online: 26 OCT 1998 | DOI: 10.1002/14651858.CD002003